Aperio Group, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q2 2020$129,000
+344.8%
15,382
+262.1%
0.00%
Q2 2019$29,0004,2480.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$5,147,0002.57%
ETF MANAGERS GROUP, LLC 14,101,511$14,243,0000.27%
Ikarian Capital, LLC 948,526$968,0000.07%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 289,627$295,0000.04%
Platform Technology Partners 60,000$61,0000.03%
PINNACLE ASSOCIATES LTD 966,014$985,0000.02%
XTX Topco Ltd 41,599$42,0000.01%
Virtu Financial LLC 160,380$164,0000.01%
Tekla Capital Management LLC 413,481$422,0000.01%
Aries Wealth Management 23,400$24,0000.01%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders